PETA is happy to announce that it’ll bankroll a $50,000 grant to fund a first-of-its-kind research to discover the precise explanation why makes an attempt to develop a vaccine in opposition to HIV have failed to provide a viable one for people.

No vaccine for HIV exists, regardless of billions in taxpayer funding and many years of analysis. In an effort to interrupt this stagnation, PETA is providing this beneficiant funding for a researcher to conduct a systemic evaluation of research wherein monkeys have been used to check HIV vaccines and examine that knowledge to the testing of those self same vaccines in people.

Solely people contract HIV and develop AIDS. However nonhuman primates have been the go-to mannequin for HIV analysis. On the nation’s seven federally funded primate analysis facilities, experimenters infect macaques with simian immunodeficiency virus (SIV), which is exclusive to African primates, or they use an engineered SIV/HIV concoction to get round this species-specific dilemma.

Many years of analysis on primates who cannot contract HIV has resulted in a pile of monkey corpses however zero vaccines. This systematic evaluation will supply perception into why that’s, as a substitute of losing effort and time on the identical merciless strategies.”

Dr. Emily Trunnell, PETA neuroscientist

Graduate college students and post-doctoral researchers are inspired to use. Candidates ought to submit an in depth proposal, together with a curriculum vitae, to Dr. Emily Trunnell at See the total submission pointers .

Functions are due June 16. The recipient can be introduced in July.

Research present that 90% of fundamental analysis, most of which includes animals, fails to result in therapies for humans-;but the Nationwide Institutes of Well being spends practically half its annual funds on animal research. PETA’s Analysis Modernization Deal maps out a method for changing the usage of animals in experiments with human-relevant strategies and presents the U.S. authorities’s personal proof that 95% of all new drugs that take a look at protected and efficient in animal exams fail in human medical trials.